At a glance
ClinicalIndex Comparison Record- ✓Stroke survivors at least 90 days from most recent hemorrhagic or nonhemorrhagic stroke
- ✓Age 18–80 years
- ✓Unilateral hemiparesis (one-sided weakness)
- ✓Medically stable
- ✕Require an ankle-foot orthosis (AFO) to maintain knee stability during stance phase of gait
- ✕Edema of the affected lower limb interfering with safe and effective use of the peroneal nerve stimulator
- ✕Skin breakdown of the affected lower limb interfering with safe and effective use of the peroneal nerve stimulator
- ✕Absent sensation of the affected lower limb
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Functional Electrical Stimulation for Footdrop in Hemiparesis
In Brief
A clinical study evaluating Odstock Dropped-Foot Stimulator (ODFS), Conventional Standard of Care, and 1 other intervention for Stroke and Hemiplegia. Completed, enrolled 110 participants across 1 site.
Detailed Summary
The objective of this research is to determine if electrical stimulation can improve the strength and coordination of the lower limb muscles, and the walking ability of stroke survivors. The knowledge gained from this study may lead to enhancements in the quality of life of stroke survivors by improving their neurological recovery and mobility. The results may lead to substantial changes in the standard of care for the treatment of lower limb hemiparesis after stroke.
Study Details
Timeline
Interventions
Device implementation \& use for \~13 weeks (until 2nd Outcomes Assessment (1st post-treatment Outcomes Assessment)). The ODFS then will be returned to the investigators.
Conventional standard of care (which may include implementation \& use of a study-specific Custom Molded Hinged Ankle Foot Orthosis (AFO)) for \~13 weeks (until 2nd Outcomes Assessment (1st post-treatment Outcomes Assessment)). The AFO, if implemented, may continue to be used afterwards since it is an element of the standard of care for this patient population.
Traditional physical therapy treatment for 12 weeks.